SEC Form 4 · accession 0001179110-15-006172
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Tzianabos
Officer — President and CSO
Period of report
Apr 9, 2015
Accepted (ET)
Apr 9, 2015 · 1:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 9, 2015 | P | 225 | $28.77 | A | 400 | D | |
| Common Stock | holding | — | — | — | 1,000 | I | by IRA |
Table II — derivative securities
No Table II lines on this filing.